ADAM GILMAN: Open Payments
NPI 1518493634 · MANCHESTER, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 11 payments from 3 companies in 2025. Trend: 2023 $427 · 2024 $143 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 9 | $473 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $126 |
| ABBVIE INC. | 1 | $92 |
Products named: Auvelity, CAPLYTA, VRAYLAR.
Industry payments across NH — which companies pay providers there.
